UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (19), p.8066-8075

2008

Volltextzugriff (PDF)

Listeria monocytogenes-Derived Listeriolysin O Has Pathogen-Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability

Clinical and Vaccine Immunology, 2013-01, Vol.20 (1), p.77-84

2013

Volltextzugriff (PDF)

A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors

Clinical cancer research, 2009-02, Vol.15 (3), p.924-932

2009

Volltextzugriff (PDF)

Retrorectal teratoma: A case report with insight on treatment and outcomes

Asian journal of surgery, 2024-08, Vol.47 (8), p.3648-3649

2024

Volltextzugriff (PDF)

Listeria monocytogenes-Based Antibiotic Resistance Gene-Free Antigen Delivery System Applicable to Other Bacterial Vectors and DNA Vaccines

Infection and Immunity, 2004-11, Vol.72 (11), p.6418-6425

2004

Volltextzugriff (PDF)

Listeria -based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors

Vaccine, 2008-09, Vol.26 (41), p.5315-5320

2008

Volltextzugriff (PDF)

Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105

Cancer Immunology, Immunotherapy, 2011-07, Vol.60 (7), p.931-942

2011

Volltextzugriff (PDF)

The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy

Cancer Immunology, Immunotherapy, 2012-05, Vol.61 (5), p.689-700

2012

Volltextzugriff (PDF)

A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

Nature medicine, 1995-05, Vol.1 (5), p.471-477

1995

Volltextzugriff (PDF)

Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy

Cancer Immunology, Immunotherapy, 2010-07, Vol.59 (7), p.1049-1058

2010

Volltextzugriff (PDF)

Relationship between the risk factors of cardiovascular disease by testing biochemical markers and young men with erectile dysfunction: a case-control study

Translational andrology and urology, 2021-02, Vol.10 (2), p.724-733

2021

Volltextzugriff (PDF)

Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (24), p.8821-8825

2004

Volltextzugriff (PDF)

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma

Cancer Immunology, Immunotherapy, 2008-04, Vol.57 (4), p.493-505

2008

Volltextzugriff (PDF)

Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine

Cancer research (Chicago, Ill.), 1995-11, Vol.55 (21), p.4776-4779

1995

Volltextzugriff (PDF)

Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer

Cancer immunity, 2007-02, Vol.7, p.2-2

2007

Volltextzugriff (PDF)

Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization

Viral immunology, 2009-06, Vol.22 (3), p.195-204

2009

Volltextzugriff (PDF)

The Induction of HIV Gag-Specific CD8+ T Cells in the Spleen and Gut-Associated Lymphoid Tissue by Parenteral or Mucosal Immunization with Recombinant Listeria monocytogenes HIV Gag

The Journal of immunology (1950), 2003-05, Vol.170 (10), p.5176-5187

2003

Volltextzugriff (PDF)

Regression of Established Human Papillomavirus Type 16 (HPV-16) Immortalized Tumors In Vivo by Vaccinia Viruses Expressing Different Forms of HPV-16 E7 Correlates with Enhanced CD8+ T-Cell Responses That Home to the Tumor Site

Journal of Virology, 2001-10, Vol.75 (20), p.9654-9664

2001

Volltextzugriff (PDF)

Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine

Cancer research (Chicago, Ill.), 1999-10, Vol.59 (20), p.5264-5269

1999

Volltextzugriff (PDF)

Tumor sensitivity to IFN-γ is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors

Cancer Immunology, Immunotherapy, 2005-05, Vol.54 (5), p.477-488

2005

Volltextzugriff (PDF)

Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine

Archives of otolaryngology--head & neck surgery, 2004-01, Vol.130 (1), p.92

2004

Volltextzugriff (PDF)

Tumor sensitivity to IFN-? is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors

Cancer Immunology, Immunotherapy, 2005-05, Vol.54 (5), p.477-488

2005

Volltextzugriff (PDF)

The Tumor Recall Response of Antitumor Immunity Primed by a Live, Recombinant Listeria monocytogenes Vaccine Comprises Multiple Effector Mechanisms

Clinical immunology (Orlando, Fla.), 2001-03, Vol.98 (3), p.346-357

2001

Volltextzugriff (PDF)

T cells from unprimed mice respond to the self antigen heme, in a class II restricted manner, at a frequency similar to alloresponses

International immunology, 1995-05, Vol.7 (5), p.771-783

1995

Volltextzugriff (PDF)

Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16

The Journal of immunology (1950), 2001-12, Vol.167 (11), p.6471-6479

2001

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(51)
Tagungsberichte
(1)

Sprache

Englisch
(47)
Chinesisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(28)
Animals
(22)
Mice
(22)
Female
(16)
Biological And Medical Sciences
(15)
Medical Sciences
(14)
Mice, Inbred C57bl
(13)
Oncology
(13)
Immunology
(12)
Antineoplastic Agents
(11)
Humans
(11)
Immunotherapy
(11)
Listeria Monocytogenes
(11)
Pharmacology. Drug Treatments
(11)
Cd8-Positive T-Lymphocytes - Immunology
(10)
Listeria Monocytogenes - Immunology
(10)
Antigens, Neoplasm - Immunology
(9)
Cancer Vaccines - Immunology
(9)
Mice, Inbred Balb C
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature

Listeria monocytogenes-Derived Listeriolysin O Has Pathogen-Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability

A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors

Retrorectal teratoma: A case report with insight on treatment and outcomes

Listeria monocytogenes-Based Antibiotic Resistance Gene-Free Antigen Delivery System Applicable to Other Bacterial Vectors and DNA Vaccines

Listeria -based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors

Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105

The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy

A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

Listeria-derived ActA is an effective adjuvant for primary and metastatic tumor immunotherapy

Relationship between the risk factors of cardiovascular disease by testing biochemical markers and young men with erectile dysfunction: a case-control study

Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7

Listeriolysin O is an improved protein carrier for lymphoma immunoglobulin idiotype and provides systemic protection against 38C13 lymphoma

Regression of established tumors in mice mediated by the oral administration of a recombinant Listeria monocytogenes vaccine

Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer

Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization

The Induction of HIV Gag-Specific CD8+ T Cells in the Spleen and Gut-Associated Lymphoid Tissue by Parenteral or Mucosal Immunization with Recombinant Listeria monocytogenes HIV Gag

Regression of Established Human Papillomavirus Type 16 (HPV-16) Immortalized Tumors In Vivo by Vaccinia Viruses Expressing Different Forms of HPV-16 E7 Correlates with Enhanced CD8+ T-Cell Responses That Home to the Tumor Site

Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine

Tumor sensitivity to IFN-γ is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors

Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine

Tumor sensitivity to IFN-? is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors

The Tumor Recall Response of Antitumor Immunity Primed by a Live, Recombinant Listeria monocytogenes Vaccine Comprises Multiple Effector Mechanisms

T cells from unprimed mice respond to the self antigen heme, in a class II restricted manner, at a frequency similar to alloresponses

Two Listeria monocytogenes Vaccine Vectors That Express Different Molecular Forms of Human Papilloma Virus-16 (HPV-16) E7 Induce Qualitatively Different T Cell Immunity That Correlates with Their Ability to Induce Regression of Established Tumors Immortalized by HPV-16

Suchergebnisse filtern